Clinical Trial Update: Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery [Phase 2]

View source ↗

Summary

Astellas reports results from a Phase 2 trial evaluating ASP1128 (MA-0217) in subjects at risk for acute kidney injury after CABG and/or valve surgery; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• ASP1128 (MA-0217) (ASP1128)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Acute Kidney Injury (AKI) | Phase 2 | Status: COMPLETED | Results posted: 2022-10-04